2-amino-1,3,4-oxadiazoles
801
2273; (c) Kiselyov A M M, Oprea T, Lemcke H, Weiss D
G, Ikizalp N N, Kuznetsov S A and Semenov V V 2010
Eur. J. Med. Chem. 45 1683; (d) Yale H L and Losee K
1966 J. Med. Chem. 9 478; (e) Ghirian D, Schwatz I and
Simiti I 1974 Farmacia 22 141
one pot methodology with a range of substrates and the
results are presented in table 2.
All the products were obtained in good to excellent
yield with electron donating hydrazides giving slightly
higher yields than the electron withdrawing counter-
parts. Study of the steric effect showed that hindered
substrates (table 2, entry 12 and 16) reacted slowly even
though good yields were obtained in such cases. The
mild conditions are tolerable to different heterocyclic
ring systems including isonicotinic and indole rings
(table 2, entry 15 and 19). The steric factor played a
negligent role with respect to isocyanates since primary,
secondary and tertiary isocyanates produced similar
yields and similar reactivity.
3. (a) Zou X J, Lai L H, Jin G Y and Zhang Z X 2002 J.
Agric. Food. Chem. 50 3757; (b) Chudgar N K, Shah
S N and Vora R A 1989 Mol. Cryst. Lig. Cryst. 172
51
4. Chekler E L P, Elokdah H M and Butera J 2008 Tetra-
hedron Lett. 49 6709
5. Dolman S J, Gosselin F, Shea P D and Davies I W 2006
J. Org. Chem. 71 9548
6. (a) Chaudhari P S, Pathare S P and Akamanchi K G 2012
J. Org. Chem. 77 3716; (b) Amir M and Kumar S 2004
Ind. J. Heterocycl. Chem. 14 51
7. (a) Gavrilyuk J I, Lough A J and Batey R A 2008 Tetra-
hedron Lett. 49 4746; (b) Rostom S A, Shalaby M A and
Demellawy E M 2003 Eur. J. Med. Chem. 38 959; (c)
Zhang X, Xiao Y and Qian X 2008 Angew. Chem.Intl.
Ed. 47 8025
4. Conclusion
8. (a) Kilburn J P, Lau J and Jones, R C F 2001 Tetrahedron
Lett. 42 2583; (b) Severinsen R, Kilburn J P and Lau J F
2005 Tetrahedron 61 5565
9. (a) Sharma S, Srivastava V K and Kumar A 2002 Eur.
J. Med. Chem. 37 689. (b) Hamad A S S and Hashem A
2002 J. Heterocycl. Chem. 39 1325
10. (a) Appel R, Kleinstuck R and Ziehn K D 1971 Chem.
Ber. 104 1335; (b) Dumciute J, Martynaitis V, Holzer
W, Manelinckx S, Kimpe N D and Sackus A S 2006
Tetrahedron 62 3309
11. Brain C T, Paul J M, Loong Y and Oakley P J 1999
Tetrahedron Lett. 40 3275
We have described an efficient procedure for the prepa-
ration of 2-amino-1,3,4-oxadiazoles from acylhydra-
zides and isocyanates under one-pot conditions using
T3P. Unlike other coupling reagents, T3P has effec-
tively activated one of the oxygens in acylsemicar-
bazides to produce the cyclic compound. The conditions
are simple, mild, non-toxic, environmentally benign,
scalable and thus it is one of the robust methods avail-
able for the preparation of 2-amino-1,3,4-oxadiazoles.
12. Baxendale I R, Ley S V and Martinelli M M 2005
Tetrahedron 61 5323
Supplementary Information
13. Levins C G and Wan Z K 2008 Org. Lett. 10 1755
14. Maghari S, Ramezanpour S, Darviche F, Balalaie S,
Rominger F and Bijanzadeh H R 2013 Tetrahedron 69
2075
15. Xie Y, Liu J, Yang P, Shi X and Li J 2011 Tetrahedron
67 5369
All additional information pertaining to characteriza-
tion of all new compounds are given the supplementary
information along with copies of 1H and 13C spectra and
16. (a) Esher R and Buning P 1986 Angew. Chem. Int. Ed.
Engl. 25 277; (b) Klose J, Bienert M, Mollenkop, C,
Wehle D, Zhang, C -W, Carpino L A and Henklein P
1999 Chem. Commun. 1847
17. (a) Desroses M, Wieckowski M and Odell L R 2011
Tetrahedron Lett. 52 4417; (b) Augustine J K, Bombrun
A and Venkatachaliah S 2011 Tetrahedron Lett. 52 6814;
(c) Wen X, Bakali J E, Deprez-Poulain R and Deprez B
2012 Tetrahedron Lett. 53 2440; (d) Poojari S P, Naik P
and Krishnamurthy G 2012 Tetrahedron Lett. 53 4639;
(e) Augustine J K, Vairaperumal V, Narasimhan S,
Alagarsamy P and Radhakrishnan A 2009 Tetrahedron
65 9989
Acknowledgements
SS & SU are thankful to Dr. G.Manickam for his valu-
able advice and Syngene International Ltd. for pro-
viding facilities to carry out the research work.
References
1. Bostrom J, Hogner A, Linas A, Wellner E and Plowright
A 2012 J. Med. Chem. 55 1817
2. (a) Nofal Z M, Fahmy H H and Mohamed H S 2002
Arch.Pharm. Res. 25 28; (b) Chapleo C B, Myers M,
Saville J F, Smith A C B, Stilling M R, Tulloch I F,
Walter D S and Welbourn A P 1986 J. Med. Chem. 29
18. (a) Meudt A, Scherer S and Nerdinger S WO
2005070879; (b) Hermann S DE 10063493 (2002); (c)
Augustine J K, Bombrun A, Ramappa B and Boodappa
C 2012 Tetrahedron Lett. 53 4422